Eduardo Moreno Escobar-rekin lankidetzan egindako argitalpenak (3)

2023

  1. A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study

    The Lancet, Vol. 401, Núm. 10374, pp. 347-356

2021

  1. Pharmacogenetic polymorphisms affecting bisoprolol response

    Biomedicine and Pharmacotherapy, Vol. 142

2015

  1. Influence of the HER2 Ile655Val polymorphism on trastuzumab-induced cardiotoxicity in HER2-positive breast cancer patients: A meta-analysis

    Pharmacogenetics and Genomics, Vol. 25, Núm. 8, pp. 388-393